Vyvanse shortages return

Less than two months after the TGA declared shortages of Vyvanse to be “resolved” the regulator is now reporting the medication is once again in short supply  The Therapeutic Goods Administration (TGA) is reporting that Vyvanse (lisdexamfetamine dimesilate) 20mg capsules are once again in short supply.   Takeda Pharmaceuticals Australia notified the regulator of the